PlainRecalls
FDA Drug Moderate Class II Terminated

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)

Reported: April 13, 2022 Initiated: March 31, 2022 #D-0746-2022

Product Description

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)

Reason for Recall

Presence of foreign substance: Presence of stainless steel particulates in tablets.

Details

Recalling Firm
MERCK SHARP & DOHME CORP
Units Affected
3600 cartons
Distribution
Nationwide in the USA
Location
Whitehouse Station, NJ

Frequently Asked Questions

What product was recalled?
Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03). Recalled by MERCK SHARP & DOHME CORP. Units affected: 3600 cartons.
Why was this product recalled?
Presence of foreign substance: Presence of stainless steel particulates in tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 13, 2022. Severity: Moderate. Recall number: D-0746-2022.